Eli Lilly and Company Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (37)

Latest Posts

About This Stock More About This Stock
Eli Lilly And Co. Q1 Profit & Revenue Beat The Street
Article By: Lorimer Wilson
Tuesday, April 25, 2017 10:24 AM EDT
Eli Lilly and Co. posted better than expected first quarter earnings results and backed its full-year outlook, as its new product launches are going mostly as expected.
In this article: LLY
Read
The Coca-Cola Co. Misses On Earnings, Eli Lilly And Co. Beats Estimates
Article By: ValueWalk
Tuesday, April 25, 2017 8:27 AM EDT
Coca-Cola reported adjusted earnings of 43 cents per share on $9.1 billion in revenue, compared to the analyst estimates of 44 cents per share and $8.9 billion in revenue.
In this article: LLY, KO
Read
18 Drugs To Lose Patents In 2017; Could Jeopardize $26.5B For Big Pharma
Article By: Lorimer Wilson
Saturday, April 22, 2017 8:24 PM EDT
With 18 branded drugs on the line, patent losses this year could jeopardize $26.5 billion in annual sales from Big Pharma, projected to be the biggest fall-off until at least 2025.
In this article: AZN, BMY, GSK, LLY, MRK, PFE, SNY, RHHBY, TEVA
Read
Incyte, Eli Lilly Plunge After FDA Won't Approve Arthritis Drug
Article By: The Fly
Monday, April 17, 2017 12:52 PM EDT
Shares of drugmaker Incyte (INCY) and mega-cap partner Eli Lilly (LLY​) are sliding after the Food and Drug Administration rejected their application for rheumatoid arthritis therapy baricitinib in its current form, due to safety concerns.
In this article: INCY, LLY Also: GILD, GLPG, PFE, ABBV
Read
FDA Rejects Eli Lilly’s Blockbuster Contender Baricitinib
Article By: Lorimer Wilson
Friday, April 14, 2017 12:05 PM EDT
The FDA has rejected Eli Lilly’s (LLY) blockbuster rheumatoid-arthritis contender baricitinib, saying that the pharma giant will need to gather more data..
In this article: ABBV, LLY, INCY, SNY, REGN
Read

PARTNER HEADLINES

Latest Tweets for $LLY

No tweets yet!